Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Recruitment of Endogenous Circulating Progenitor Cells for Cardiac Regeneration Using Enhanced Tissue-Engineered Biomatrices
FY 2009-10
Summary
Coronary artery disease (CAD) is a condition in which the arteries that supply blood to the heart harden and become obstructed due to the formation of plaques. In Canada, CAD is the most prevalent cause of death for both men and women. Medical advances, such as bypass grafting and percutaneous coronary intervention have been able to temporarily extend the lives of numerous afflicted individuals; however, despite this , CAD still remains an incurable disease. Compensatory mechanisms that assist the heart in maintaining cardiac output place extra burden on the weakened myocardium, which eventually leads to end-stage heart failure, progressive fall in cardiac output, or development of multi-organ failure from reduced blood flow and ultimately death. This has lead to interest in tissue engineering and stem cell therapy to restore perfusion to the ischemic heart, which is the ultimate goal of our research. Though much research has been done, problems with cell therapy such as non-specific homing, cell activation and transplanted cell survival still remain. Our project involves the use of an enhanced collagen based scaffold to improve mobilization, homing and engraftment of the bone marrow stem cells to the site of injury. We are also using a stem cell homing protein, called SDF-1, to further increase the body's endogenous stem cell response. The goal of this research is to rebuild new blood vessels, thereby, returning the blood flow to the heart. This research can have a huge impact by biologically restoring the heart of the millions affected with heart disease, who have run out of other medical options. To our knowledge, this is the first investigation of a combination of growth factor and binding proteins in a matrix designed to recruit the host's own progenitor cells to the infarcted heart.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
201213
Name
Sofrenovic Tanja
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Recruitment of Endogenous Circulating Progenitor Cells for Cardiac Regeneration Using Enhanced Tissue-Engineered Biomatrices
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Angiogenesis; Cell Homing; Endothelial Progenitor Cells; Ischemia; Rat Myocardial Infarct Model; Revascularization; Tissue Engineering
Abstract
Coronary artery disease (CAD) is a condition in which the arteries that supply blood to the heart harden and become obstructed due to the formation of plaques. In Canada, CAD is the most prevalent cause of death for both men and women. Medical advances, such as bypass grafting and percutaneous coronary intervention have been able to temporarily extend the lives of numerous afflicted individuals; however, despite this , CAD still remains an incurable disease. Compensatory mechanisms that assist the heart in maintaining cardiac output place extra burden on the weakened myocardium, which eventually leads to end-stage heart failure, progressive fall in cardiac output, or development of multi-organ failure from reduced blood flow and ultimately death. This has lead to interest in tissue engineering and stem cell therapy to restore perfusion to the ischemic heart, which is the ultimate goal of our research. Though much research has been done, problems with cell therapy such as non-specific homing, cell activation and transplanted cell survival still remain. Our project involves the use of an enhanced collagen based scaffold to improve mobilization, homing and engraftment of the bone marrow stem cells to the site of injury. We are also using a stem cell homing protein, called SDF-1, to further increase the body's endogenous stem cell response. The goal of this research is to rebuild new blood vessels, thereby, returning the blood flow to the heart. This research can have a huge impact by biologically restoring the heart of the millions affected with heart disease, who have run out of other medical options. To our knowledge, this is the first investigation of a combination of growth factor and binding proteins in a matrix designed to recruit the host's own progenitor cells to the infarcted heart.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sofrenovic, Tanja
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~